PATENT CLAIM ANALYSIS

Application Number: 15965114
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "262100"]

Abstract:
Disclosed herein are methods for treating a cancer comprising: a. administering a Btk inhibitor to a subject sufficient to result in an increase or appearance in the blood of a subpopulation of lymphocytes defined by immunophenotyping; b. determining the expression profile of one or more biomarkers from one or more subpopulation of lymphocytes; and c. administering a second agent based on the determined expression profile.

Claim (Index 156):
The method of  claim 155 , wherein the human subject is an adult suffering from a hematological malignancy selected from the group consisting of chronic lymphocytic leukemia, small lymphocytic lymphoma, and Waldenstrom's macroglobulinemia, and further wherein the therapeutically effective amount is 420 mg administered in three of said capsules.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.4375
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15066600', '15659803', '15054952', '15066491', '14091196']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8494681916495889
- 35 USC 102 Novelty (BERT): 0.6010969101548764
- Combined Prediction Score: 0.8246310635001177
- Mean Citation Score: 743.8886219999997
- Max Citation Score: 755.1629
- Similarity Product: 493.4909136261225

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test